About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Florida | 678 Studies

Clinical Trials Prostate CancerFlorida

Prostate Cancer Clinical Trials in Florida

Find 678 clinical trials for prostate cancer near Florida. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 678 trials

CompletedInBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer SurvivorsThis clinical trial studies how well the InBody Band 3 fitness tracker works to improve physical activity, body composition, and quality of life in Black prostate cancer survivors.NCT06703996·Jacksonville, Florida and 1 other Active not recruitingEffectiveness of the SpaceOAR Vue System in Subjects With Prostate CancerTo demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat…NCT04905069·Fort Myers, Florida and 29 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedDarolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerThe purpose of the study is to assess the efficacy and safety of BAY1841788 (darolutamide (ODM-201)) in combination with standard androgen deprivation therapy (ADT) and docetaxel…NCT02799602·Chandler, Arizona and 321 others

Active not recruitingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerThis study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment…NCT03860272·Scottsdale, Arizona and 17 others

CompletedStudy Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic…NCT01193257·Anchorage, Alaska and 77 others

RecruitingAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC)…NCT05939414·Fayetteville, Arkansas and 143 others

CompletedAnalyses of Human Samples Collected in Clinical TrialsCancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes.NCT00339664·Washington D.C., District of Columbia and 16 others

CompletedRADTOX: Measuring Radiation Toxicity Using Circulating DNAThis research study is being done to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications.NCT02941029·Gainesville, Florida and 1 other

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

RecruitingAssessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTThe purpose of this research study is to test the efficacy of ADT on prostate-specific membrane antigen (PSMA), a marker of prostate cancer, before and after scheduled ADT.NCT07455903·Miami, Florida

CompletedEffect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidThis is an open-label exploratory study of CTAP101 Capsules in patients with bone metastases arising from either breast or prostate cancer, who are taking anti-resorptive therapy.NCT02274623·Long Beach, California and 5 others

CompletedIntramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate CancerIntramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients with Prostate Cancer.NCT01491971·Homewood, Alabama and 14 others

RecruitingCollection and Measurement of Biomarkers in Prostate Cancer Radiotherapy PatientsThe purpose of this research study is to learn about: 1) How standard radiation treatment to prostate (primary radiotherapy) or the pelvis after prostatectomy (postoperative…NCT02997709·Miami, Florida

CompletedGabapentin in Treating Hot Flashes in Patients With Prostate CancerRATIONALE: Gabapentin may be effective in relieving hot flashes in men who have prostate cancer.NCT00028574·Mobile, Alabama and 169 others

CompletedHormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as ketoconazole may stop the production of androgens.NCT00027859·Huntsville, Alabama and 97 others

RecruitingA Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to evaluate whether TJ101, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with advanced solid…NCT07181473·Orlando, Florida and 6 others

CompletedStudy Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486Population pharmacokinetic and pharmacodynamic data from Study FE200486 CS06 and FE200486 CS02 provided further knowledge of the optimal dose regimens for FE200486 (degarelix).NCT00117949·Anaheim, California and 11 others

CompletedA Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy and safety BIND-014 in patients with metastatic castration-resistant prostate cancer (mCRPC).NCT01812746·Los Angeles, California and 7 others

CompletedRadiotherapy Assessments During Intervention ANd Treatment (RADIANT)Collect blood samples and associated clinical data prior to, during, and post radiation treatment.NCT03133286·Compton, California and 3 others

CompletedMultimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast CancerRATIONALE: A multimedia educational program may help patients with newly diagnosed prostate cancer and breast cancer reduce distress, make informed treatment decisions, and…NCT00830635·Miami, Florida and 2 others

PreviousPage 3 of 34Next

Other Conditions in Florida

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma